PSA Today 30 Dec: Last trading session of 2021 / Considering Eisai and Biogen / Tanaka's shares rise on Northvolt LiB news – Nikkei 225 -0.40%
Japan Market Comment by Pelham Smithers and Joel ScheimanTags: Biogen (BIIB US), Samsung BioLogics (207940 KS), Eisai (4523 JT), Naver (035420 KS), Z Holdings (4689 JT), SoftBank Group (9984 JT), Micron (MU US), Screen Holdings (7735 JT), RS Technologies (3445 JT), Konami Holdings (9766 JT), Nintendo (7974 JT), Taiko Pharmaceutical (4574 JT), Genmab (GMAB US), Merck (MRK US), Takeda Pharmaceutical (4502 JT), Showa Denko (4004 JT), Mizuho Financial Group (8411 JT), Tanaka Chemical (4080 JT), Northvolt, Sumitomo Chemical (4005 JT), Volkswagen (VOW GR)
Main Points
• Tokyo ends potentially promising year on dull, tired note
• Eisai watches as Biogen gets put into play
• Tanaka Chemical shares rise on LiB announcement
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.